Category: Regulation & Policy
Regulation & Policy market research reports by Mordor Intelligence Inc
-
GMP Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
GMP Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029) The GMP Testing Service Market size is estimated at USD 1.44 billion in 2024, and is expected to reach USD 2 billion by 2029, growing at a CAGR of 6.84% during the forecast period (2024-2029). Lockdowns were implement ... Read More
-
Pharmacovigilance and Drug Safety Software Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
Pharmacovigilance and Drug Safety Software Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028) The pharmacovigilance and drug safety software market is currently valued at USD 165.08 million and it is expected to register a CAGR of nearly 6.49% during the forecast period. The evolv ... Read More
-
Pharmacovigilance Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
Pharmacovigilance Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028) The pharmacovigilance market is expected to register a CAGR of 8.65 % during the forecast period (2022-2027). The evolving threat of COVID-19 infection is adversely affecting communities, industries, businesses, ... Read More
-
GMP Testing Service Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
GMP Testing Service Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) The GMP testing service market is expected to register a CAGR of 6.97% during the forecast period (2022 - 2027). Lockdowns were implemented following the COVID-19 outbreak in order to stop the virus's spread. B ... Read More
-
Pharmacovigilance Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Pharmacovigilance Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) The pharmacovigilance market is expected to register a CAGR of 8.65 % during the forecast period (2022-2027). The evolving threat of COVID-19 infection is adversely affecting communities, industries, businesses, ... Read More
-
Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) The Pharmaceutical CDMO Market is expected to register a CAGR of 7.29% during the forecast period (2022 - 2027). The contract development and manufacturing ... Read More
-
Pharmaceutical Analytical Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Pharmaceutical Analytical Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) The global pharmaceutical analytical testing market is estimated to be USD 7,137.92 million in 2021. It is expected to reach USD 11,387.35 million by 2027, registering a CAGR of 8.20% from 2022 to ... Read More
-
Blockchain Market in Healthcare - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Blockchain Market in Healthcare - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) The blockchain market in healthcare was valued at USD 2.12 billion in 2020, and is expected to reach USD 3.49 billion by 2026, with a CAGR of 8.7% during the forecast period, 2021 - 2026. In 2018, the Illi ... Read More
-
Pharmacovigilance and Drug Safety Software Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Pharmacovigilance and Drug Safety Software Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) The pharmacovigilance and drug safety software market estimated to be valued at USD USD 163.08 million in 2020 and is expected to reach approximately USD 238.68 million in 2026, registeri ... Read More
-
Orphan Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Orphan Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) The orphan drugs market is expected to register a CAGR of 11.5% over the forecast period. Factors that are responsible for the growth of this market include market exclusivity for orphan drug developers, the rising pr ... Read More
Research Assistance
